Dawn E. Sailer

539 total citations
10 papers, 384 citations indexed

About

Dawn E. Sailer is a scholar working on Epidemiology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Dawn E. Sailer has authored 10 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Dawn E. Sailer's work include Burn Injury Management and Outcomes (4 papers), Injury Epidemiology and Prevention (2 papers) and Toxin Mechanisms and Immunotoxins (1 paper). Dawn E. Sailer is often cited by papers focused on Burn Injury Management and Outcomes (4 papers), Injury Epidemiology and Prevention (2 papers) and Toxin Mechanisms and Immunotoxins (1 paper). Dawn E. Sailer collaborates with scholars based in United States. Dawn E. Sailer's co-authors include Craig B. Langman, Amy S. Paller, Ian Landells, Bari B. Cunningham, Gordon L. Klein, David N. Herndon, Bettina F. Cuneo, Joseph Barnett, Martin L. Nusynowitz and Lyle D. Broemeling and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Kidney International and Clinical Chemistry.

In The Last Decade

Dawn E. Sailer

9 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn E. Sailer United States 7 162 140 81 74 60 10 384
Danuta Chlebna‐Sokół Poland 10 93 0.6× 72 0.5× 13 0.2× 40 0.5× 24 0.4× 55 343
SJ Gallacher United Kingdom 11 75 0.5× 73 0.5× 10 0.1× 30 0.4× 57 0.9× 21 535
Hwan Soo Kim South Korea 13 72 0.4× 62 0.4× 36 0.4× 16 0.2× 85 1.4× 64 486
Juan González‐Moreno Spain 10 125 0.8× 26 0.2× 28 0.3× 9 0.1× 43 0.7× 43 317
N. Meddeb Tunisia 10 39 0.2× 128 0.9× 18 0.2× 32 0.4× 27 0.5× 37 325
Reto Kurmann United States 12 76 0.5× 45 0.3× 41 0.5× 28 0.4× 80 1.3× 40 345
Russell Wesson United States 12 168 1.0× 37 0.3× 10 0.1× 50 0.7× 13 0.2× 26 504
Mahima Agrawal India 9 81 0.5× 19 0.1× 61 0.8× 32 0.4× 37 0.6× 33 313
Payam Tristani‐Firouzi United States 14 129 0.8× 100 0.7× 215 2.7× 123 1.7× 10 0.2× 20 599
Gianfranco Rizzato Italy 11 131 0.8× 23 0.2× 32 0.4× 49 0.7× 277 4.6× 17 597

Countries citing papers authored by Dawn E. Sailer

Since Specialization
Citations

This map shows the geographic impact of Dawn E. Sailer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn E. Sailer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn E. Sailer more than expected).

Fields of papers citing papers by Dawn E. Sailer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn E. Sailer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn E. Sailer. The network helps show where Dawn E. Sailer may publish in the future.

Co-authorship network of co-authors of Dawn E. Sailer

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn E. Sailer. A scholar is included among the top collaborators of Dawn E. Sailer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn E. Sailer. Dawn E. Sailer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sailer, Dawn E., et al.. (1999). Immunoradiometric Assay for Intact Human Osteocalcin(1–49) without Cross-Reactivity to Breakdown Products. Clinical Chemistry. 45(4). 526–531. 6 indexed citations
2.
Höppe, Bernd, et al.. (1998). Simultaneous determination of oxalate, citrate and sulfate in children's plasma with ion chromatography: Technical Note. Kidney International. 53(5). 1348–1352. 45 indexed citations
3.
Cunningham, Bari B., Ian Landells, Craig B. Langman, Dawn E. Sailer, & Amy S. Paller. (1998). Topical calcipotriene for morphea/linear scleroderma. Journal of the American Academy of Dermatology. 39(2). 211–215. 123 indexed citations
4.
Langman, Craig B., Dawn E. Sailer, & Bernd Höppe. (1998). The Use of Random Urine Samples for Quantification of Urinary Anion Excretions † 1820. Pediatric Research. 43. 310–310. 1 indexed citations
5.
Klein, Gordon L., Steven E. Wolf, Craig B. Langman, et al.. (1998). Effect of Therapy with Recombinant Human Growth Hormone on Insulin-Like Growth Factor System Components and Serum Levels of Biochemical Markers of Bone Formation in Children After Severe Burn Injury1. The Journal of Clinical Endocrinology & Metabolism. 83(1). 21–24. 2 indexed citations
6.
Klein, Gordon L., Craig B. Langman, Dawn E. Sailer, & David N. Herndon. (1998). Acute Uncoupling of Bone Turnover in Children following Severe Burn Injury 1817. Pediatric Research. 43. 310–310.
7.
Klein, Gordon L., et al.. (1997). Dysregulation of calcium homeostasis after severe burn injury in children: Possible role of magnesium depletion. The Journal of Pediatrics. 131(2). 246–251. 67 indexed citations
8.
Sailer, Dawn E., et al.. (1997). Five Osteocalcin Assays Compared: Tracer Specificity, Fragment Interference, and Calibration. Clinical Chemistry. 43(7). 1240–1241. 10 indexed citations
9.
Klein, Gordon L., David N. Herndon, Craig B. Langman, et al.. (1995). Long-term reduction in bone mass after severe burn injury in children. The Journal of Pediatrics. 126(2). 252–256. 110 indexed citations
10.
Pope, Richard M., Robert S. Wallis, Dawn E. Sailer, Thomas M. Buchanan, & Mohammad A. Pahlavani. (1991). T cell activation by mycobacterial antigens in inflammatory synovitis. Cellular Immunology. 133(1). 95–108. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026